Insmed to present at chardan's 7th annual genetic medicines conference

Bridgewater, n.j. , sept. 26, 2023 /prnewswire/ -- insmed incorporated (nasdaq: insm), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present in a fireside chat at chardan's 7th annual genetic medicines conference in new york, on tuesday, october 3, 2023 at 2:00 p.m.
INSM Ratings Summary
INSM Quant Ranking